ivWatch Announces Sedeer Medical Services as Additional Global Distribution Partner

ivWatch enters distribution agreement with Sedeer Medical Services, a major provider and distributor of medical and health care products in Qatar.

HAMPTON, Va., December 11, 2018 – ivWatch, the only provider of continuous patient monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, recently entered into a distribution agreement with Sedeer Medical Services. Sedeer Medical Services is a major provider and distributor of medical and health care products in Qatar.

“Qatar’s health sector has an exceptional international reputation for offering quality medical care,” said Babu Kupparayil, managing director at Sedeer Medical. “We’re eager to help institutions meet their health care visions by offering the most advanced technology allowing better patient outcomes during IV therapy.”

Upon completion of regulatory approval requirements, Sedeer Medical will distribute and provide training and support for the ivWatch Model 400 patient monitor to new customers as the exclusive distributor in Qatar.

“With a joint mission of working to set new standards of care in the field of quality health care, we are confident Sedeer Medical will be successful in introducing ivWatch breakthrough technology to hospitals and facilities in search of the best solution for early detection of peripheral IV leakage,” said Chuck Egress, vice president of business development and emerging markets at ivWatch.

For further information about ivWatch and their industry partners, visit  ivwatch.com/about-us/partnerships/.

About ivWatch:
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLCivwatch.com

Erin Wendell
Mobile (757) 633-4688